Reply: factor II/X-guided warfarin monitoring for congenital factor VII deficiency after mechanical valve replacement
Xiaokang Luo, Xinjian Yan · 2026
Read Reply: factor II/X-guided warfarin monitoring for congenital factor VII deficiency after mechanical valve replacement by Xiaokang Luo, Xinjian Yan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13617820.txt.
Description
Xiaokang Luo and Xinjian Yan write a reply defending their anticoagulation strategy for a patient with congenital factor VII deficiency who received a mechanical heart valve. Readers had questioned monitoring blood thinning by factors II and X instead of the standard INR test. The authors explain why warfarin is unavoidable here: direct oral anticoagulants failed in mechanical valve trials and remain contraindicated, leaving warfarin as the only endorsed option.
Their core argument: INR misleads in this condition. The test weights factors II, VII, and X equally, yet warfarin's protection comes mainly from suppressing the long-lived factors II and X. The patient's inborn factor VII shortage inflates INR on its own. In their case, a falsely high INR delayed anticoagulation until day six after surgery and the patient suffered a brain clot. Monitoring factors II and X directly, they argue, reflects true anticoagulation intensity and avoids dangerous misjudgments.
Catalog record
| CREATOR | Xiaokang Luo, Xinjian Yan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 4 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |